Celdoxome pegylated liposomal 2 mg / mL concentrate for dispersion for infusion

Licence status
Authorised: 15/09/2022
Active substances
DOXORUBICIN HYDROCHLORIDE
Dosage Form
Concentrate for dispersion for infusion
Licence number
EU/1/22/1666/001-004
Licence holder
Yes Pharmaceutical Development Services GmbH

Product documents

Licence information

ATC code
L01DB01 doxorubicin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/09/2022